Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

413

HTML

3419

Tables (1-3)

295

Sum=4127

Publishing Process of This Article

Item

Count

Browse

1326

Download

932

Sum=2258

May 27, 2013 (publication date) through Feb 14, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. May 27, 2013; 5(5): 275-280
Published online May 27, 2013. doi: 10.4254/wjh.v5.i5.275

Table 2 Distribution of the grades of the liver histology and the median cumulative dose

Histology grade	No.	Median MTX cumulative dose (mg)
Normal	6	2285
I	62	2885
II	23	1800
III	7	1500
IV	0	-
Total	98	2500

MTX: Methotrexate.

Citation: Yeo CM, Chong VH, Earnest A, Yang WL. Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis. World J Hepatol 2013; 5(5): 275-280
URL: https://www.wjgnet.com/1948-5182/full/v5/i5/275.htm
DOI: https://dx.doi.org/10.4254/wjh.v5.i5.275